Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$1.22 - $2.57 $124,264 - $261,769
101,856 New
101,856 $207,000
Q4 2021

Feb 14, 2022

SELL
$1.63 - $3.41 $21,753 - $45,509
-13,346 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$3.11 - $4.75 $6,720 - $10,264
-2,161 Reduced 13.94%
13,346 $43,000
Q2 2021

Aug 16, 2021

BUY
$4.94 - $9.43 $76,604 - $146,231
15,507 New
15,507 $77,000
Q4 2020

Feb 16, 2021

SELL
$0.73 - $3.22 $16,651 - $73,448
-22,810 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$0.73 - $1.04 $2,035 - $2,899
-2,788 Reduced 10.89%
22,810 $20,000
Q2 2020

Aug 14, 2020

BUY
$0.8 - $2.1 $20,478 - $53,755
25,598 New
25,598 $25,000

About SECOND SIGHT MEDICAL PRODUCTS INC


  • Ticker EYES
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,136,400
  • Market Cap $54.4M
  • Description
  • Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulati...
More about EYES
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.